Uniform Mesh Structure Innovation: Tetra-Gel
Gellycle Co., Ltd.
Control Gel, Transform Medical Care
As a pioneering bio-venture, we leverage the groundbreaking Tetra-Gel technology developed by Professor Sakai at the University of Tokyo for medical and industrial applications. Our mission is to harness this highly biocompatible, cutting-edge gel technology to innovate across multiple medical products, introducing a novel approach we call Gel Medicine. Through strategic partnerships, we aim to forge new markets and drive innovation.
In today's world, countless diseases remain without a cure. Our core mission is to address these unmet medical needs, utilizing our world-leading gel control technology to enhance the quality of life for patients globally.
BUSINESS DETAILS
- Company Name
- Gellycle Co., Ltd.
- Date of Establishment
- 8/1/2018
- Head Office Location
- Sakae bldg. 2F, 3-38-1 Hongo, Bunkyo-ku, Tokyo 113-0033
- Location of Factories
- Sakae bldg. 2F, 3-38-1 Hongo, Bunkyo-ku, Tokyo 113-0033
- Representative
- Kousuke Masui
- Company Site (Japanese)
- https://gellycle.com/home
- Company Site (English)
- https://gellycle.com/home-en
- Major Business Partners
- Cosmo Bio, Kaigen Pharma, Medico's Hirata, Nof, Xiamen Sinopeg Biotech
- Industry
- Medical device manufacturer
- Achievements
- Berkeley SkyDeck 2023, University Venture Award 2023, University Venture Award Special Prize, ICC Kyoto 2021 Real Tech Catapult Championship